- Elucidating how researchers are using menstrual effluent to track fertility, inflammation, and disease.
- Consumer Adoption & Clinical Validation – The path to making menstrual-based diagnostics a mainstream health tool.
- Investment & Industry Growth – The market potential of menstrual-based biomarkers in diagnostics and therapeutics.
Session Topics:
Reproductive Health
Speaker(s):
Lara Zibners
Co-Founder
Calla Lily Clinical Care
Time:
12:00 PM - 12:30 PM
Agenda Track No.:
Track 5
Session Type:
Track